Stanford Neurosciences Institute

Showing 1-10 of 201 Results

  • Gregory W. Albers, MD

    Gregory W. Albers, MD

    The Coyote Foundation Professor and Professor, by courtesy, of Neurosurgery at the Stanford University Medical Center

    Current Research and Scholarly Interests Our group’s research focus is the acute treatment and prevention of cerebrovascular disorders. Our primary interest is the use of diffusion- and perfusion-weighted MRI to expand the treatment window for ischemic stroke. We are also conducting clinical studies of both neuroprotective and thrombolytic strategies for the treatment of acute stroke and investigating new antithrombotic strategies for stroke prevention.

  • Katrin Andreasson

    Katrin Andreasson

    Professor of Neurology at the Stanford University Medical Center

    Current Research and Scholarly Interests Our research focuses on the investigation of the brain’s innate immune response, and the role that maladaptive microglial activity plays in initiation and progression of neurological disease.

  • Ann M. Arvin

    Ann M. Arvin

    Vice Provost and Dean of Research, Lucile Salter Packard Professor of Pediatrics and Professor of Microbiology and Immunology

    Current Research and Scholarly Interests Our laboratory investigates the pathogenesis of varicella zoster virus (VZV) infection, focusing on the functional roles of particular viral gene products in pathogenesis and virus-cell interactions in differentiated human cells in humans and in Scid-hu mouse models of VZV cell tropisms in vivo, and the immunobiology of VZV infections.

  • Ben Barres

    Ben Barres

    Professor of Neurobiology, of Developmental Biology, of Neurology and, by courtesy, of Ophthalmology

    Current Research and Scholarly Interests Our lab is interested in the neuronal-glial interactions that underlie the development and function of the mammlian central nervous system.

  • Michael Bassik

    Michael Bassik

    Assistant Professor of Genetics

    Current Research and Scholarly Interests We are interested in the mechanism by which bacterial toxins, viruses, and protein aggregates hijack the secretory pathway and kill cells. More broadly, we investigate how diverse stresses (biological, chemical) signal to the apoptotic machinery.

    To pursue these interests, we develop widely applicable new technologies to screen and measure genetic interactions; these include high-complexity shRNA libraries, which have allowed the first systematic genetic interaction maps in mammalian cells.

  • Gill Bejerano

    Gill Bejerano

    Associate Professor of Developmental Biology, of Computer Science and of Pediatrics (Genetics)

    Current Research and Scholarly Interests Dr. Bejerano, co-discoverer of ultraconserved elements, studies the Human Genome. His research focuses on genome sequence and function in both humans and related primate, mammalian and vertebrate species. He is deeply interested in mapping both coding and non-coding genome sequence variation to phenotype differences, and in extracting specific genetic insights from high throughput sequencing measurements, in the contexts of development and developmental abnormalities.

  • Rebecca Bernert

    Rebecca Bernert

    Assistant Professor of Psychiatry and Behavioral Sciences (Public Mental Health and Population Sciences)

    Bio Dr. Bernert is Director of the Suicide Prevention Research Laboratory within the Stanford Mood Disorders Center. She is a suicidologist, with subspecialty expertise in suicide prevention clinical trials and evidence-based standardized suicide risk assessment and best practice management. She has subspecialty training in behavioral sleep medicine, with a background in sleep and circadian physiology. Her program utilizes cognitive, biologic (e.g., fMRI), and behavioral testing paradigms, with an emphasis on translational therapeutics. Dr. Bernert has collaborated with NIH, DOD, DARPA, SAMHSA, and the White House on suicide prevention initiatives; and recently contributed to the 2014 VACO Mental Health Innovations for Suicide Prevention Workgroup and the 2013 VA/DOD Clinical Practice Guidelines (CPG) for the Assessment and Management of Patients at Risk for Suicide. Her research focuses on the development of novel therapeutic targets for suicide prevention across the lifespan, particularly those aiming to reduce stigma and enhance access to care. A specific focus of this work emphasizes the use of low-risk intervention approaches for the prevention of suicide. Dr. Bernert has several suicide prevention trials currently underway, funded by NIH and DOD, testing the preliminary efficacy of a non pharmacological insomnia treatment on suicidal behaviors. Within this framework, we are interested in the investigation of transdiagnostic risk factors and candidate biomarkers that may inform the pathogenesis of risk and treatment innovation. Advisory and advocacy work, focused on the way in which such research guides public health policy, dissemination, and national strategies for suicide prevention, has been an extension of this work. Most recently, this includes local initiatives to establish guidelines for lethal means restriction advocacy and implementation on a broad scale.

  • Sandip Biswal, MD

    Sandip Biswal, MD

    Associate Professor of Radiology (General Radiology) at the Stanford University Medical Center

    Current Research and Scholarly Interests Chronic pain sufferers are unfortunately limited by poor diagnostic tests and therapies. Our lab is interested in 'imaging pain' by using multimodality molecular imaging techniques to study nociception and neuronal inflammation as a means of improving objective, image-guided diagnosis and treatment of chronic pain disorders. We develop new molecular contrast agents for use in positron emission tomography (PET) and magnetic resonance imaging (MRI), working towards eventual clincal translation.